MYOS RENS Technology Inc. (Nasdaq: MYOS) announced that an institutional investor will purchase approximately $2.125 million of common stock through a registered direct offering. Shares of the bionutrition and biotherapeutics company soared 99 cents to close at $3.65.
MYOS REN Technology announced registered direct offering
February 03, 2017 at 18:05 PM EST
